Langevin AM - Search Results

1

Adriamycin and cis-platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation.

Langevin AM, Pierro A, Liu P, Filler RM, Greenberg ML. Langevin AM, et al. Med Pediatr Oncol. 1990;18(3):181-4. doi: 10.1002/mpo.2950180303. Med Pediatr Oncol. 1990. PMID: 1691816

2

Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.

Koren G, Ferrazini G, Sulh H, Langevin AM, Kapelushnik J, Klein J, Giesbrecht E, Soldin S, Greenberg M. Koren G, et al. Among authors: langevin am. N Engl J Med. 1990 Jul 5;323(1):17-21. doi: 10.1056/NEJM199007053230104. N Engl J Med. 1990. PMID: 2355954 Free article.

3

Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia.

Koren G, Langevin AM, Olivieri N, Giesbrecht E, Zipursky A, Greenberg M. Koren G, et al. Among authors: langevin am. Am J Dis Child. 1990 Oct;144(10):1135-7. doi: 10.1001/archpedi.1990.02150340081028. Am J Dis Child. 1990. PMID: 2403095

4

Preoperative chemotherapy in 'unresectable' hepatoblastoma.

Pierro A, Langevin AM, Filler RM, Liu P, Phillips MJ, Greenberg ML. Pierro A, et al. Among authors: langevin am. J Pediatr Surg. 1989 Jan;24(1):24-8; discussion 29. doi: 10.1016/s0022-3468(89)80294-5. J Pediatr Surg. 1989. PMID: 2542511

5

Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night.

Langevin AM, Koren G, Soldin SJ, Greenberg M. Langevin AM, et al. Lancet. 1987 Aug 29;2(8557):505-6. doi: 10.1016/s0140-6736(87)91808-3. Lancet. 1987. PMID: 2887790 Clinical Trial. No abstract available.

6

Phase I therapy trials in children with cancer.

Shah S, Weitman S, Langevin AM, Bernstein M, Furman W, Pratt C. Shah S, et al. Among authors: langevin am. J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):431-8. doi: 10.1097/00043426-199809000-00005. J Pediatr Hematol Oncol. 1998. PMID: 9787315 Review.

7

Nutritional vitamin B12 deficiency in infancy: three case reports and a review of the literature.

Doyle JJ, Langevin AM, Zipursky A. Doyle JJ, et al. Among authors: langevin am. Pediatr Hematol Oncol. 1989;6(2):161-72. doi: 10.3109/08880018909034282. Pediatr Hematol Oncol. 1989. PMID: 2702070 Review.

8

Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy.

Dupuis LL, Tamura RN, Kelly KM, Krischer JP, Langevin AM, Chen L, Kolb EA, Ullrich NJ, Sahler OJZ, Hendershot E, Stratton A, Sung L, McLean TW. Dupuis LL, et al. Among authors: langevin am. Pediatr Blood Cancer. 2019 Apr;66(4):e27584. doi: 10.1002/pbc.27584. Epub 2018 Dec 18. Pediatr Blood Cancer. 2019. PMID: 30561134 Clinical Trial.

9

Neuroblastoma presenting as acute monoblastic leukemia.

Boyd JE, Parmley RT, Langevin AM, Saldívar VA. Boyd JE, et al. Among authors: langevin am. J Pediatr Hematol Oncol. 1996 May;18(2):206-12. doi: 10.1097/00043426-199605000-00024. J Pediatr Hematol Oncol. 1996. PMID: 8846141 Review.

10

Anemia and hepatosplenomegaly as presenting features in a child with rickets and secondary myelofibrosis.

Gruner BA, DeNapoli TS, Elshihabi S, Britton HA, Langevin AM, Thomas PJ, Weitman SD. Gruner BA, et al. Among authors: langevin am. J Pediatr Hematol Oncol. 2003 Oct;25(10):813-5. doi: 10.1097/00043426-200310000-00015. J Pediatr Hematol Oncol. 2003. PMID: 14528107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters